Tau/MAP6 ratio as a master switch for microtubule dynamics plasticity

Target: MAPT Composite Score: 0.750 Price: $0.50 Citation Quality: 70% neurodegeneration Status: proposed
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
✓ All Quality Gates Passed
Quality Report Card click to collapse
B+
Composite: 0.750
Top 12% of 1402 hypotheses
T4 Speculative
Novel AI-generated, no external validation
Needs 1+ supporting citation to reach Provisional
A Mech. Plausibility 15% 0.80 Top 20%
B+ Evidence Strength 15% 0.75 Top 16%
B+ Novelty 12% 0.75 Top 35%
B+ Feasibility 12% 0.75 Top 25%
F Impact 12% 0.00 Top 50%
F Druggability 10% 0.00 Top 50%
F Safety Profile 8% 0.00 Top 50%
F Competition 6% 0.00 Top 50%
F Data Availability 5% 0.00 Top 50%
F Reproducibility 5% 0.00 Top 50%
Evidence
6 supporting | 0 opposing
Citation quality: 0%
Debates
1 session B+
Avg quality: 0.72
Convergence
0.00 F 20 related hypothesis share this target

Hypotheses from Same Analysis (2)

These hypotheses emerged from the same multi-agent debate that produced this hypothesis.

Tau/MAP6 antagonism in neurodegeneration progression
Score: 0.650 | Target: MAP6
Developmental stage-specific dominance of tau vs MAP6 function
Score: 0.550 | Target: MAPT

Description

The relative abundance of tau versus MAP6 on individual microtubules determines the balance between stable and labile domains, creating a spatial code for where dynamic remodeling (axon guidance, branching) versus stable support (process integrity) occurs

Prediction: Manipulating the tau:MAP6 expression ratio will shift the entire spectrum of neuronal plasticity phenotypes in a predictable dose-response manner

No AI visual card yet

Curated Mechanism Pathway

Curated pathway diagram from expert analysis

flowchart TD
    A["MAPT/Tau Protein
Microtubule Stabilizer"] B["CDK5/GSK3B Activation
Kinase Dysregulation"] C["Tau Hyperphosphorylation
Ser396/Thr231/Ser202"] D["Tau Detachment
Microtubule Destabilized"] E["Tau Oligomers
Paired Helical Filaments"] F["Neurofibrillary Tangles
Intraneuronal Inclusions"] G["Axonal Transport Failure
Synaptic Dysfunction"] H["Neurodegeneration
Tauopathy Spread"] A --> B B --> C C --> D D --> E E --> F D --> G G --> H F --> H style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7 style C fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a style H fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.80 (15%) Evidence 0.75 (15%) Novelty 0.75 (12%) Feasibility 0.75 (12%) Impact 0.00 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.00 (5%) KG Connect 0.50 (8%) 0.750 composite
6 citations 5 with PMID 5 medium Validation: 0% 6 supporting / 0 opposing
For (6)
5
No opposing evidence
(0) Against
High Medium Low
High Medium Low
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
3
1
2
MECH 3CLIN 1GENE 2EPID 0
ClaimStanceCategorySourceStrength ↕Year ↕Quality ↕PMIDsAbstract
Antagonistic roles of tau and MAP6 in regulating n…SupportingGENEJ Cell Sci MEDIUM2024-PMID:39257379-
Tau filaments with the Alzheimer fold in human MAP…SupportingMECHNat Struct Mol … MEDIUM2025-PMID:40044789-
MAPT mutations, tauopathy, and mechanisms of neuro…SupportingGENELab Invest MEDIUM2019-PMID:30742061-
Endolysosomal impairment by binding of amyloid bet…SupportingMECHAutophagy MEDIUM2023-PMID:36843263-
Tau-targeting antisense oligonucleotide MAPT(Rx) i…SupportingCLINNat Med MEDIUM2023-PMID:37095250-
The relative abundance of tau versus MAP6 on indiv…SupportingMECH------
Legacy Card View — expandable citation cards

Supporting Evidence 6

The relative abundance of tau versus MAP6 on individual microtubules determines the balance between stable and…
The relative abundance of tau versus MAP6 on individual microtubules determines the balance between stable and labile domains, creating a spatial code for where dynamic remodeling (axon guidance, branching) versus stable support (process integrity) occurs
Antagonistic roles of tau and MAP6 in regulating neuronal development. MEDIUM
J Cell Sci · 2024 · PMID:39257379
Tau filaments with the Alzheimer fold in human MAPT mutants V337M and R406W. MEDIUM
Nat Struct Mol Biol · 2025 · PMID:40044789
MAPT mutations, tauopathy, and mechanisms of neurodegeneration. MEDIUM
Lab Invest · 2019 · PMID:30742061
Endolysosomal impairment by binding of amyloid beta or MAPT/Tau to V-ATPase and rescue via the HYAL-CD44 axis … MEDIUM
Endolysosomal impairment by binding of amyloid beta or MAPT/Tau to V-ATPase and rescue via the HYAL-CD44 axis in Alzheimer disease.
Autophagy · 2023 · PMID:36843263
Tau-targeting antisense oligonucleotide MAPT(Rx) in mild Alzheimer's disease: a phase 1b, randomized, placebo-… MEDIUM
Tau-targeting antisense oligonucleotide MAPT(Rx) in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.
Nat Med · 2023 · PMID:37095250

Opposing Evidence 0

No evidence recorded
Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Artifact Review | 4 rounds | 2026-04-25 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

Evaluation of Sun et al. (2024): Antagonistic Roles of Tau and MAP6 in Regulating Neuronal Development

1. Key Scientific Contributions

1.1 Demonstration of a Functional Tau:MAP6 Yin-Yang System


This paper provides direct experimental evidence that tau and MAP6 operate as antagonistic regulators of microtubule dynamics during neuronal development. The authors show that depletion of each protein produces opposite phenotypes—tau knockdown accelerates neuronal development while MAP6 knockdown retards it—establishing a functional binary switch governing cytoskeletal dynamics. This exte

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

Critical Evaluation of Sun et al. (2024): Antagonistic Roles of Tau and MAP6 in Neuronal Development

1. Methodological Weaknesses and Limitations

1.1 Incomplete Mechanistic Validation


The paper attributes observed phenotypes to opposite roles in "regulating microtubule stability," yet provides minimal direct evidence for this claim. The abstract itself acknowledges that tau and MAP6 are "multifunctional proteins." Without direct measurements of microtubule dynamics (e.g., EB comet tracking, acetylation status, or detyrosinated tubulin ratios), the mechanistic basis remains inferenti

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

Expert Assessment: Sun et al. (2024) - Antagonistic Roles of Tau and MAP6

Summary Scores

  • Novelty: 6.5/10
  • Experimental Rigor: 7/10
  • Overall Contribution: 7/10

1. Novelty Assessment

The paper sits in a middle ground between established concept and new experimental contribution. The idea that tau destabilizes microtubules while MAP6 stabilizes them has been discussed in the literature, and prior work established their ultrastructural segregation on individual microtubules. However, this paper moves beyond correlative observations to provide **functional validation

Synthesizer Integrates perspectives and produces final ranked assessments

{
"summary": "This paper demonstrates that tau and MAP6 function as antagonistic regulators of neuronal development through their opposite effects on microtubule stability. Using primary rodent neuronal cultures, the authors show that tau depletion accelerates neuronal development, process formation, growth cone turning, and axonal branching, while MAP6 depletion produces opposite phenotypes. Critically, co-depletion of both proteins negates individual phenotypes, establishing a functional yin-yang relationship. In vivo validation confirms that MAP6 depletion impairs neuronal migration. The

Price History

0.740.750.76 0.77 0.73 2026-04-252026-04-252026-04-25 Market PriceScoreevidencedebate 1 events
7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0000
Events (7d)
1

Clinical Trials (0) Relevance: 85%

No clinical trials data available

📚 Cited Papers (5)

MAPT mutations, tauopathy, and mechanisms of neurodegeneration.
Laboratory investigation; a journal of technical methods and pathology (2019) · PMID:30742061
No extracted figures yet
Endolysosomal impairment by binding of amyloid beta or MAPT/Tau to V-ATPase and rescue via the HYAL-CD44 axis in Alzheimer disease.
Autophagy (2023) · PMID:36843263
No extracted figures yet
Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.
Nature medicine (2023) · PMID:37095250
No extracted figures yet
Antagonistic roles of tau and MAP6 in regulating neuronal development.
J Cell Sci (2024) · PMID:39257379
No extracted figures yet
Tau filaments with the Alzheimer fold in human MAPT mutants V337M and R406W.
Nature structural & molecular biology (2025) · PMID:40044789
No extracted figures yet

📙 Related Wiki Pages (0)

No wiki pages linked to this hypothesis yet.

࢐ Browse all wiki pages

📓 Linked Notebooks (0)

No notebooks linked to this analysis yet. Notebooks are generated when Forge tools run analyses.

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas
→ Browse all arenas & tournaments

📊 Resource Economics & ROI

Moderate Efficiency Resource Efficiency Score
0.50
31.7th percentile (747 hypotheses)
Tokens Used
0
KG Edges Generated
0
Citations Produced
6

Cost Ratios

Cost per KG Edge
0.00 tokens
Lower is better (baseline: 2000)
Cost per Citation
0.00 tokens
Lower is better (baseline: 1000)
Cost per Score Point
0.00 tokens
Tokens / composite_score

Score Impact

Efficiency Boost to Composite
+0.050
10% weight of efficiency score
Adjusted Composite
0.800

How Economics Pricing Works

Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.

High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.

Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.

Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.

Related Hypotheses

Glymphatic-Mediated Tau Clearance Dysfunction
Score: 0.821 | neuroscience
Excitatory Neuron Synaptic Dysfunction and Mitochondrial Stress via MAPT (tau)
Score: 0.790 | neurodegeneration
Dual-Circuit Tau Vulnerability Cascade
Score: 0.754 | neuroscience
Tau dysfunction destabilizes labile pool
Score: 0.750 | neurodegeneration
Cholinergic Basal Forebrain-Hippocampal Circuit Protection
Score: 0.742 | neuroscience

Estimated Development

Estimated Cost
$0
Timeline
0 months

🧪 Falsifiable Predictions (2)

2 total 0 confirmed 0 falsified
IF the tau:MAP6 expression ratio is experimentally shifted via CRISPR activation of MAP6 promoter in mature hippocampal neurons (increasing MAP6 relative to endogenous tau), THEN microtubule dynamic instability will increase by ≥40% measured by EB3 comet tracking lifetime within 72 hours, AND stable microtubule post-translational modification signatures (acetylated tubulin) will decrease by ≥30% compared to controls.
pending conf: 0.45
Expected outcome: Dose-dependent increase in microtubule dynamics (shorter EB3 comet lifetimes, increased catastrophe frequency) and decrease in stable acetylated microtubule networks as MAP6 expression rises
Falsified by: If microtubule dynamic parameters remain within ±15% of baseline despite >2-fold increase in MAP6 expression, the hypothesis is falsified
Method: Primary mouse hippocampal neuron culture transfected with CRISPRa-MAP6 or CRISPRa-tau constructs at DIV14-18; EB3-mApple live imaging with automated comet tracking; immunocytochemistry for ac-tubulin quantification
IF MAPT-knockout neurons (which have low tau) are crossed with MAP6-knockout neurons to create a double knockout, THEN rescued expression of MAP6 at 3x endogenous levels will normalize axon branch dynamics to wildtype levels (within ±20%) within 5 days, whereas rescued MAP6 at 0.3x levels will fail to normalize dynamics.
pending conf: 0.40
Expected outcome: Rescue with high MAP6 restores dynamic remodeling rates to wildtype baseline; rescue with low MAP6 leaves dynamics elevated
Falsified by: If both high and low MAP6 rescue conditions produce identical axon branch dynamics (within experimental noise), the ratio-dependent model is falsified
Method: Human iPSC-derived cortical neurons with CRISPR KO of MAPT or MAP6; AAV-mediated inducible MAP6 expression at defined levels; longitudinal confocal imaging of axon branching over 5 days post-induction

Knowledge Subgraph (0 edges)

No knowledge graph edges recorded

3D Protein Structure

🧬 MAPT — PDB 5O3L Click to expand 3D viewer

Experimental structure from RCSB PDB | Powered by Mol* | Rotate: click+drag | Zoom: scroll | Reset: right-click

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)